Ocular adverse events*
| Serious ocular adverse event | No of subjects | % Per injection |
| Endophthalmitis | 2† | 0.05% |
| Vitreous haemorrhage | 2 | 0.05% |
| Conjunctival irritation | 1 | 0.02% |
| Retinal haemorrhage | 1 | 0.02% |
| Retinal tear | 1 | 0.02% |
| Vitreous opacities | 1 | 0.02% |
| Ocular adverse events reported in ≥5% of study eyes, N (%) | ||
| Punctate keratitis | 73 (12.9) | |
| Eye pain | 61 (10.7) | |
| Vitreous floaters | 57 (10.0) | |
| Conjunctival haemorrhage | 36 (6.3) | |
| Eye irritation | 34 (6.0) | |
| Visual acuity reduced | 31 (5.5) | |
| Macular degeneration | 28 (4.9) | |